Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥145.31B | 18.2x | -1.3 | CN¥54.38 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥44.54B | 23.7x | 1.02 | CN¥25.16 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥41.73B | 43.7x | -0.72 | CN¥48.45 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.8% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥30.92B | 19.8x | 0.14 | CN¥68.75 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥17.33B | -20.2x | -0.95 | CN¥41.54 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥16.36B | -662.8x | -6.8 | CN¥37.35 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥14.62B | -153.3x | 0.8 | CN¥38.33 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.95B | -0.3x | -1.68 | CN¥187.25 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.60B | -5.5x | 0.46 | CN¥28.24 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.39B | -15,580x | CN¥15.49 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | ||
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.21B | -28.9x | -1.88 | CN¥11.95 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥7.80B | -21.2x | 17.64 | CN¥13.32 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥7.55B | -20.6x | -0.54 | CN¥18.36 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥7.22B | 54.5x | -1.43 | CN¥59.71 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.31B | -6.4x | 0.45 | CN¥15.60 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.51B | 37.5x | -3.77 | CN¥13.89 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.75B | 90.9x | 1.38 | CN¥12.12 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.46B | 31.4x | -9.11 | CN¥47.17 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.7% Upside | Upgrade to Pro+ | |
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.28B | 54.2x | -0.91 | CN¥48.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.16B | 34x | 0.99 | CN¥15.24 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.7% Downside | Upgrade to Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.89B | 21.7x | 1.66 | CN¥35.02 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.82B | 26.6x | 0.7 | CN¥22.68 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.67B | 21x | -1.16 | CN¥34.04 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.67B | -9x | 0.54 | CN¥6.64 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.6% Upside | Upgrade to Pro+ | |
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.66B | -17.6x | 0.06 | CN¥27.51 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.28B | 478.1x | -5.29 | CN¥24.57 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.16B | 71.1x | 1.5 | CN¥8.32 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.6% Upside | Upgrade to Pro+ | |
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3B | 45.8x | -11.65 | CN¥11.84 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥2.97B | -3.2x | 0.07 | CN¥5.98 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥2.90B | -13.6x | -0.4 | CN¥29.18 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |